Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table A-2. Breast Cancer Chemoprevention: Search Strategy Results

Search No. Search Terms No. of Results
1 Explode breast neoplasms 90,662
2 Limit 1 to (human and female) 70,714
3 Explode Tamoxifen 6,743
4 Explode estrogen antagonists or raloxifene 10,229
5 Explode estrogen antagonists or keoxifen 10,206
6 Selective estrogen receptor modulator 32
7 3 or 4 or 5 or 6 10,230
8 2 and 7 3,756
9 Limit 8 to controlled clinical trial 45
10 Limit 8 to randomized controlled trials 447
11 Explode randomized controlled trials 12,678
12 Explode random allocation 38,532
13 Explode single-blind method 4,241
14 Explode double-blind method 55,099
15 11 or 12 or 13 or 14 98,408
16 8 and 15 349
17 9 or 10 or 16 635

Return to Document

 

AHRQ Advancing Excellence in Health Care